<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="28077">Rifampicin</z:chebi> is an <z:chebi fb="1" ids="33282">antibacterial agent</z:chebi> that is widely used in <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> and <z:e sem="disease" ids="C0023343" disease_type="Disease or Syndrome" abbrv="">leprosy</z:e> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Interestingly, some experimental studies indicate that <z:chebi fb="0" ids="28077">rifampicin</z:chebi> acts as a <z:chebi fb="1" ids="29191">hydroxyl radical</z:chebi> scavenger and a <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> receptor activator </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, the neuroprotective effect of <z:chebi fb="0" ids="28077">rifampicin</z:chebi> was evaluated after transient and permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Anaesthetized male C57BL/6j mice were submitted to permanent or transient thread occlusion of the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>Reperfusion in <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> was initiated 30 min later by thread retraction </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="28077">Rifampicin</z:chebi> or vehicle were applied intraperitoneally before permanent or immediately after 30 min of <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Later, 24 h after permanent or <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e>, animals were re-anesthetized and decapitated </plain></SENT>
<SENT sid="7" pm="."><plain>Brain injury was evaluated by triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining (TTC), terminal transferase biotinylated-<z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling (TUNEL) and <z:chebi fb="0" ids="52815">cresyl violet</z:chebi> staining </plain></SENT>
<SENT sid="8" pm="."><plain>A 20-mg/kg sample of <z:chebi fb="0" ids="28077">rifampicin</z:chebi> showed a significant neuroprotection after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The number of TUNEL-positive cells in the striatum, where disseminated tissue injury was observed, was also reduced by application of <z:chebi fb="0" ids="28077">rifampicin</z:chebi> as compared with vehicle-treated animals </plain></SENT>
<SENT sid="10" pm="."><plain>The present report shows that administration of <z:chebi fb="0" ids="28077">rifampicin</z:chebi> efficiently reduces brain injury after permanent and transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in mice </plain></SENT>
</text></document>